{
    "nctId": "NCT00556218",
    "briefTitle": "Meditation and Cognitive Function in Women With Breast Cancer",
    "officialTitle": "Feasibility Study of Meditation, Cognitive Function, and Quality of Life in Women With Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 47,
    "primaryOutcomeMeasure": "Number of Eligible Women Approached Who Consented to be in Trial (Feasibility)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Women with stage I - III breast cancer who have undergone chemotherapy (either neoadjuvant or adjuvant) 6 - 60 months prior to recruitment.\n2. Women who report cognitive impairment since starting chemotherapy as assessed by four questions from the FACT-Cog.\n3. Women must be 18 years or older.\n4. Women must be able to read, write and speak English.\n5. Women must be currently undergoing hormone therapy (e.g., Tamoxifen or AIs)\n6. Willing to come to MDACC for the meditation sessions and assessment sessions.\n7. Women must be within 2 hours driving distance of MDACC.\n\nExclusion Criteria:\n\n1. Women who have a documented diagnosis of a formal thought disorder (e.g., schizophrenia) will be excluded from the study.\n2. Women with metastatic disease to the brain or any past neurologic injury.\n3. Women with a Mini-Mental State Examination score of 23 or below.\n4. Women with recurrent cancer",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}